Discovery of a novel class of triazolones as Checkpoint Kinase inhibitors-Hit to lead exploration

被引：17

作者：

Oza, Vibha ^{[1
]}

Ashwell, Susan ^{[1
]}

Brassil, Patrick ^{[1
]}

Breed, Jason ^{[2
]}

Deng, Chun ^{[1
]}

Ezhuthachan, Jay ^{[1
]}

Haye, Heather ^{[2
]}

Horn, Candice ^{[1
]}

Janetka, James ^{[1
]}

Lyne, Paul ^{[1
]}

Newcombe, Nicholas ^{[2
]}

Otterbien, Ludo ^{[2
]}

Pass, Martin ^{[2
]}

Read, Jon ^{[2
]}

Roswell, Sian ^{[2
]}

Su, Mei ^{[1
]}

Toader, Dorin ^{[1
]}

Yu, Dingwei ^{[1
]}

Yu, Yan ^{[1
]}

Valentine, Anna ^{[2
]}

Webborn, Peter ^{[2
]}

White, Ann ^{[2
]}

Zabludoff, Sonya ^{[1
]}

Zheng, Xiaolan ^{[1
]}

机构：

[1] AstraZeneca R&D Boston, Waltham, MA 02451 USA

[2] AstraZeneca R&D Alderley Pk, Macclesfield SK10 4TG, Cheshire, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 17期

关键词：

Triazolones; CHK1; Checkpoint Kinase inhibitors; PROTEIN-KINASE; UCN-01;

D O I：

10.1016/j.bmcl.2010.07.015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Checkpoint Kinase-1 (Chk1, CHK1, CHEK1) is a Ser/Thr protein kinase that mediates cellular responses to DNA-damage. A novel class of Chk1 inhibitors, triazoloquinolones/triazolones (TZ's) was identified by high throughput screening. The optimization of these hits to provide a lead series is described. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5133 / 5138

页数：6

共 50 条

[31] SAR, binding mode and radioprotective effects of a novel class of checkpoint2 kinase inhibitors.
Axe, FU
Arienti, KL
Brunmark, A
McClure, K
Lee, A
Blevitt, J
Neff, D
Huang, LM
Crawford, S
Pandit, CR
Karlsson, L
Breitenbucher, JG
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U766 - U766
[32] Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors
Dwyer, Michael P.
Paruch, Kamil
Alvarez, Carmen
Doll, Ronald J.
Keertikar, Kerry
Duca, Jose
Fischmann, Thierry O.
Hruza, Alan
Madison, Vincent
Lees, Emma
Parry, David
Seghezzi, Wolfgang
Sgambellone, Nicole
Shanahan, Frances
Wiswell, Derek
Guzi, Timothy J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6216 - 6219
[33] Substituted 2-arylbenzothiazoles as kinase inhibitors: Hit-to-lead optimization
Tasler, Stefan
Mueller, Oliver
Wieber, Tanja
Herz, Thomas
Pegoraro, Stefano
Saeb, Wael
Lang, Martin
Krauss, Rolf
Totzke, Frank
Zirrgiebel, Ute
Ehlert, Jan E.
Kubbutat, Michael H. G.
Schaechtele, Christoph
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (18) : 6728 - 6737
[34] Discovery of 4-Benzylamino-Substituted α-Carbolines as a Novel Class of Receptor Tyrosine Kinase Inhibitors
Krug, Martin
Wichapong, Kanin
Erlenkamp, German
Sippl, Wolfgang
Schaechtele, Christoph
Totzke, Frank
Hilgeroth, Andreas
CHEMMEDCHEM, 2011, 6 (01) : 63 - 72
[35] Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors
Jeankumar, Variam Ullas
Reshma, Rudraraju Srilakshmi
Vats, Rahul
Janupally, Renuka
Saxena, Shalini
Yogeeswari, Perumal
Sriram, Dharmarajan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 122 : 216 - 231
[36] Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead
Terakado, Masahiko
Suzuki, Hidehiro
Hashimura, Kazuya
Tanaka, Motoyuki
Ueda, Hideyuki
Kohno, Hiroshi
Fujimoto, Taku
Saga, Hiroshi
Nakade, Shinji
Habashita, Hiromu
Takaoka, Yoshikazu
Seko, Takuya
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 913 - 918
[37] Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors
Xiu-Mei Chen
Tao Lu
Shuai Lu
Hui-Fang Li
Hao-Liang Yuan
Ting Ran
Hai-Chun Liu
Ya-Dong Chen
Journal of Molecular Modeling, 2010, 16 : 1195 - 1204
[38] Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors
Chen, Xiu-Mei
Lu, Tao
Lu, Shuai
Li, Hui-Fang
Yuan, Hao-Liang
Ran, Ting
Liu, Hai-Chun
Chen, Ya-Dong
JOURNAL OF MOLECULAR MODELING, 2010, 16 (07) : 1195 - 1204
[39] Discovery of a new class of p38 kinase inhibitors
Dumas, J
Sibley, R
Riedl, B
Monahan, MK
Lee, W
Lowinger, TB
Redman, AM
Johnson, JS
Kingery-Wood, J
Scott, WJ
Smith, RA
Bobko, M
Schoenleber, R
Ranges, GE
Housley, TJ
Bhargava, A
Wilhelm, SM
Shrikhande, A
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) : 2047 - 2050
[40] Discovery of a new class of bioavailable protein kinase inhibitors.
Velentza, A
Zasadzki, M
Haiech, J
Wainwright, M
Van Eldik, L
Watterson, DM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U25 - U25

← 1 2 3 4 5 →